Correlations of systemic immune-inflammation index and systemic inflammation response index with the risk for early-onset post-stroke depression in patients with minor stroke: a prospective observational study - Report - MDSpire
Advertisement
Correlations of systemic immune-inflammation index and systemic inflammation response index with the risk for early-onset post-stroke depression in patients with minor stroke: a prospective observational study
Clinical Report: Associations Between SII, SIRI, and Early-Onset Post-Stroke Depression
Overview
This study investigates the relationship between systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) with early-onset post-stroke depression (PSD) in minor stroke patients. Findings indicate that both SII and SIRI are associated with early-onset PSD, with correlations to depression severity.
Background
Post-stroke depression (PSD) is a common neuropsychiatric complication following ischemic stroke, affecting approximately one-third of stroke survivors. Early-onset PSD, occurring within the first two weeks post-stroke, is associated with worse clinical outcomes.
Data Highlights
Measure
Value
Patients with early-onset PSD
372 (33.42%)
Correlation with SII (r)
0.440 (p < 0.001)
Correlation with SIRI (r)
0.418 (p < 0.001)
SII OR (95% CI)
1.762 (1.261–1.946, p < 0.001)
SIRI OR (95% CI)
1.672 (1.348–1.932, p = 0.004)
AUC for SII
0.767
AUC for SIRI
0.718
AUC for combined indices
0.807
Key Findings
33.42% of patients diagnosed with early-onset PSD.
Significant positive correlation between HAMD-17 scores and SII (r = 0.440, p < 0.001).
Significant positive correlation between HAMD-17 scores and SIRI (r = 0.418, p < 0.001).
SII and SIRI are independent predictors of early-onset PSD (OR = 1.762 and OR = 1.672, respectively).
AUC for SII, SIRI, and their combination were 0.767, 0.718, and 0.807, respectively.
Clinical Implications
The findings indicate that SII and SIRI are associated with early-onset PSD.
Conclusion
SII and SIRI may serve as tools for predicting early-onset PSD in minor stroke patients.